The “Pain and Cancer” research axis is dedicated to the characterization and physio-pharmacology of pain associated with cancer, including pain linked to cancer metastases and chemo-induced peripheral neuropathies (CIPN). We are also exploring the epidemiology of pain and co-morbidities during and after cancer, as well as the study of predictive biomarkers for CIPN, such as miRNAs and proteins. Our research includes the pathophysiology of CIPN, therapeutic innovation for their treatment and the identification of predictive factors for the evolution of neuropathic pain upon diagnosis of cancer.
Journal articles
2025










2024














2023


















2022




2021










2020


















2019














Dextromethorphan and memantine after ketamine analgesia: a randomized control trial
. Drug Design, Development and Therapy, 2019, Volume 13, pp.2677-2688. ⟨10.2147/DDDT.S207350⟩. ⟨hal-02325142⟩


2018






2017








2016










2015












2014






2013








2012


2011




2010




2009
2008
2007
2006
Conference papers
2025
2024
2023
2022
2021
2019
Book sections
2018
2015
Patents
2022
Poster communications
2024
2023
2022
2019
2017


Reports
2023


2021
2020


Preprints, Working Papers, …
2022